A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment

Braden Waters1, John Muscedere

  • 1Department of Internal Medicine, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada.

Insights

Ventilator-associated pneumonia (VAP) is a common ICU infection that increases patient morbidity and mortality. This review covers updated VAP surveillance, diagnosis, and management strategies based on recent clinical evidence.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Ventilator-associated pneumonia (VAP) is a frequent nosocomial infection in intensive care units (ICUs).
  • VAP significantly increases patient morbidity, mortality, and healthcare resource utilization, including prolonged mechanical ventilation and hospital stays.
  • Accurate prevention, diagnosis, and management are crucial for critically ill patients.

Purpose of the Study:

  • To review current clinical knowledge on VAP prevention, diagnosis, and management.
  • To discuss recent updates in VAP surveillance nomenclature, including ventilator-associated conditions and events.
  • To synthesize evidence predominantly from randomized control trials and meta-analyses.

Main Methods:

  • Literature review focusing on randomized control trials (RCTs) and meta-analyses.
  • Discussion of recent nomenclature changes proposed by the Centers for Disease Control (CDC).
  • Synthesis of current clinical data for VAP prevention, diagnosis, and management.

Main Results:

  • The review addresses the clinical significance of VAP in ICUs.
  • It incorporates recent CDC proposals for VAP surveillance terminology.
  • Evidence from RCTs and meta-analyses forms the basis of the discussion.

Conclusions:

  • Updated knowledge on VAP prevention, diagnosis, and management is clinically important.
  • Recent changes in surveillance nomenclature aim to refine VAP event identification.
  • Evidence-based strategies are essential for mitigating VAP's impact on critically ill patients.

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
867